Patent Application
Utility
PCT National Stage
App. No. 19/154,281
· Confirmation No. 4433
SELINEXOR AND ANALOGS FOR USE IN THE TREAMENT OF ENDOMETRIAL CANCER IN PATIENTS WITH WILD-TYPE TP53 GENE
Inventor:
Christopher Walker
Application Undergoing Preexam Processing
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-08-06 | ADS |
Application Data Sheet | 9 | View | |
| 2025-08-06 | TRAN.LET |
Transmittal Letter | 4 | View | |
| 2025-08-06 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2025-08-06 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 1 | View | |
| 2025-08-06 | A.PE |
Preliminary Amendment | 1 | View | |
| 2025-08-06 | SPEC |
Specification | 1 | View | |
| 2025-08-06 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2025-08-06 | N417.PYMT |
Electronic Fee Payment | 2 | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 25181
- Docket No.
- KTQ-05101
- Confirmation No.
- 4433
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 19/154,281
- Effective Filing
- 2025-08-06
External Links